TEVA : Summary for Teva Pharmaceutical Industries - Yahoo Finance

U.S. Markets open in 3 hrs 49 mins

Teva Pharmaceutical Industries Limited (TEVA)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
30.76-0.84 (-2.66%)
At close: 4:00PM EDT
People also watch
MYLNVSGILDAMGNABT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close31.60
Open31.31
Bid0.00 x
Ask0.00 x
Day's Range30.22 - 31.40
52 Week Range30.22 - 56.91
Volume17,095,275
Avg. Volume9,057,045
Market Cap31.35B
Beta0.56
PE Ratio (TTM)439.43
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.36 (4.23%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • 24/7 Wall St.14 hours ago

    Express Scripts, Teva Pharmaceuticals Drop into Tuesday’s 52-Week Low Club

    Express Scripts, Teva Pharmaceuticals, Range Resources, and Nielsen posted new 52-week lows on Tuesday.

  • TheStreet.com15 hours ago

    Teva Pharmaceutical CFO Stepping Down

    It is being reported that Teva will lose its CFO.

  • Teva Pharmaceutical CFO to step down: media
    Reuters16 hours ago

    Teva Pharmaceutical CFO to step down: media

    The chief financial officer of Teva Pharmaceutical Industries (TEVA.TA), Eyal Desheh, is stepping down and will likely be appointed chairman of Isracard, Bank Hapoalim's (POLI.TA) credit card company, Israeli news websites reported on Tuesday. Desheh joined Teva as CFO in 2008 and briefly served as acting CEO from October 2013 to February 2014. Teva was left without a permanent chief executive in February after Erez Vigodman stepped down, leaving new management to restore confidence in the world's biggest generic drugmaker after a series of missteps.